Tautomycin inhibits phosphatase-dependent transformation of the rat kidney mineralocorticoid receptor

Molecular and Cellular Endocrinology

Volumn 144, Issue 1-2, 1998, Pages 119-130

  Piwien Pilipuk, G ^a   Galigniana, M D ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Mineralocorticoid receptor; Protein phosphatases; Receptor transformation; Tautomycin (rat kidney)

Indexed keywords

ACID PHOSPHATASE; ALDOSTERONE; ALKALINE PHOSPHATASE; LEVAMISOLE; MINERALOCORTICOID RECEPTOR; PHOSPHOPROTEIN PHOSPHATASE; TAUTOMYCIN; TRANSCRIPTION FACTOR;

ANIMAL TISSUE; ARTICLE; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVITY; ENZYME INHIBITION; KIDNEY; MALE; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN CONFORMATION; RAT; REACTION TIME; SIGNAL TRANSDUCTION; TEMPERATURE DEPENDENCE;

ALDOSTERONE; ALKALINE PHOSPHATASE; ANIMALS; ANTIBIOTICS, ANTIFUNGAL; CELL NUCLEUS; CELLULOSE; CENTRIFUGATION, DENSITY GRADIENT; CHROMATOGRAPHY, ION EXCHANGE; CYTOPLASM; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; KIDNEY; KINETICS; LEVAMISOLE; MALE; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN CONFORMATION; PYRANS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, MINERALOCORTICOID; SPIRO COMPOUNDS; TEMPERATURE;

EID: 0031721793     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(98)00142-7     Document Type: Article

References (61)

1. Alnemri E.S., Maksymowych A.B., Robertson N.M., Litwack G. Overexpression and characterization of the human mineralocorticoid receptor. J. Biol. Chem. 266:1991;18072-18081.
2. Arnold S.F., Obouron J.D., Yudt M.R., Carter T.H., Notides A.C. In vivo and in vitro phosphorylation of the human estrogen receptor. J. Steroid Biochem. Mol. Biol. 52:1995;159-171.
3. Arriza J.L., Weinberger C., Cerelli G. et al. Cloning of human mineralocorticoid receptor complementary DNA: structure and functional kinship with the glucocorticoid receptor. Science. 237:1987;268-275.
4. Bamberger C.M., Wald M., Bamberger A.M., Schulte H.M. Inhibition of mineralocorticoid and glucocorticoid receptor function by the heat shock protein 90-binding agent geldanamycin. Mol. Cell. Endocrinol. 131:1997;233-240.
5. Bamberger C.M., Bamberger A.M., Wald M., Chrousos G.P., Schulte H.M. Inhibition of mineralocorticoid activity by the β-isoform of the human glucocorticoid receptor. J. Steroid Biochem. Mol. Biol. 60:1997;43-50.
6. Barnett C.A., Schmidt T.J., Litwack G. Effects of calf intestinal alkaline phosphatase, phosphatase inhibitors and phosphorylated compounds on the rate of activation of glucocorticoid-receptor complexes. Biochemistry. 19:1980;5446-5455.
7. Beato M. Gene regulation by steroids hormones. Cell. 56:1989;335-344.
8. Becker W., Kentrup H., Klumpp S., Schultz J.E., Joost H.G. Molecular cloning of a protein serine/threonine phosphatase containing a putative regulatory tetratricopeptide repeat domain. J. Biol. Chem. 269:1994;22586-22592.
9. Binart N., Lomès M., Rafestin-Oblin M., Baulieu E.E. Characterization of the human mineralocorticoid receptor expressed in baculovirus system. Proc. Natl. Acad. Sci. USA. 88:1991;10681-10685.
10. Bodwell J.E., Ortí E., Coull J.M. et al. Identification of phosphorylated sites in the mouse glucocorticoid receptor. J. Biol. Chem. 266:1991;7549-7555.
11. Burton G., Galigniana M.D., deLavallaz S. et al. Sodium-retaining activity of some natural and synthetic 21-deoxysteroids. Mol. Pharmacol. 47:1995;535-543.
12. Caamaño C.A., Morano M.I., Patel P.D., Watson S.J., Akil H. A bacterially expressed mineralocorticoid receptor is associated in vitro with the 90-kilodalton heat shock protein and shows typical hormone- and DNA-binding characteristics. Biochemistry. 32:1993;8589-8595.
13. Chen M.X., McPartlin A.E., Brown L., Chen Y.H., Barker H.M., Cohen P.T. A novel human protein serine/threonine phosphatase which possesses four tetratricopeptide repeated motifs and colocalizes to the nucleus. EMBO J. 13:1994;4278-4290.
14. Chen S., Prapapanich V., Rimerman R.A., Honoré B., Smith D.F. Interactions of p60, a mediator of progesterone receptor assembly, with heat shock proteins hsp90 and hsp70. Mol. Endocrinol. 10:1996;682-693.
15. Chinkers M. Targeting of a distinctive protein-serine phosphatase to the protein kinase-like domain of the atrial natriuretic peptide receptor. Proc. Natl. Acad. Sci. USA. 91:1994;11075-11079.
16. Cohen P. Classification of protein-serine/threonine phosphatases: Identification and quantitation in cell extracts. Methods Enzymol. 201:1991;389-398.
17. Couette B, Lombès M, Baulieu E.E., Rafestin-Oblin M.E. Aldosterone antagonists destabilize the mineralocorticoid receptor. Biochem. J. 282:1992;697-702.
18. Czar M.J., Galigniana M.D., Silverstein A.M., Pratt W.B. Geldanamycin, a heat shock protein 90-binding benzoquinone ansamycin, inhibits steroid-dependent translocation of the glucocorticoid receptor from cytoplasm to the nucleus. Biochemistry. 36:1997;7776-7785.
19. Denton R.R., Koszewski N.J., Notides A.C. Estrogen receptor phosphorylation: hormonal dependence and consequence on specific DNA binding. J. Biol. Chem. 267:1992;7263-7268.
20. Dittmar K.D., Demady D.R., Stancato L.F., Krishna P., Pratt W.B. Folding of the glucocorticoid receptor by the hsp90-based chaperone machinery: the role of p23 is to dynamically stabilize receptor-hsp90 heterocomplexes formed by hsp90,·p60,·hsp70. J. Biol. Chem. 272:1997;21213-21220.
21. 2+- and okadaic acid-sensitive protein phosphatases. Biochem. J. 329:1998;283-288.
22. Emadian S.M., Luttge W.G. Effects of polyhydric and monohydric compounds on the stability of type I receptors for adrenal steroids in brain cytosol. J. Neurochem. 50:1988;1456-1460.
23. Enmark E., Gustafsson J.A Orphan nuclear receptors: the first eight years. Mol. Endocrinol. 10:1996;1293-1307.
24. Evans R.M. The steroid and thyroid hormone receptor superfamily. Science. 240:1988;889-895.
25. Faure R., Daussault J.H. Effects of adenosine triphosphate and alkaline phosphatase in solubilized 3,5,3′-triiodothyronine-binding activity. Endocrinology. 123:1988;1245-1252.
26. Funder J.W., Pearce P., Smith R., Smith I.A. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science. 242:1988;583-585.
27. Galigniana M.D. Stability study on renal type I mineralocorticoid receptor. Life Sci. 59:1996;511-521.
28. Galigniana M.D., Vicent G.P., Burton G., Lantos C.P. Features of the shuttle pair 11β-hydroxyprogesterone/11-ketoprogesterone. Steroids. 62:1997;358-364.
29. Grahame Hardie D., Haystead T.A., Sim A.T. Use of okadaic acid to inhibit protein phosphatases in intact cells. Methods Enzymol. 201:1991;469-476.
30. Hsieh J.C., Jurutka P.W., Nakajima S. et al. Phosphorylation of the vitamin D receptor by protein kinase C: biochemical and functional evaluation of the serine 51 recognition site. J. Biol. Chem. 268:1993;15118-15126.
31. Hu J.M, Bodwell J.E., Munck A Control by basal phosphorylation of cell cycle-dependent, hormone-induced glucocorticoid receptor hyperphosphorylation. Mol. Endocrinol. 11:1997;305-311.
32. Hunter T. Protein kinases and phosphatases: the ying and yang of protein phosphorylation and signaling. Cell. 80:1995;225-236.
33. Johnson J.L., Toft D.O. Binding of p23 and hsp90 during assembly with the progesterone receptor. Mol. Endocrinol. 9:1995;670-678.
34. Lin K.H., Ashizawa K., Cheng S.Y. Phosphorylation stimulates the transcriptional activity of the human β1 thyroid hormone nuclear receptor. Proc. Natl. Acad. Sci. USA. 89:1992;7737-7741.
35. Litswak S.J., Gold P.W., Whitfield H.J. The human mineralocorticoid receptor gene promotor: its structure and expression. J. Steroid Biochem. Mol. Biol. 58:1996;495-506.
36. Lombès M., Binart N., Delahaye F., Baulieu E.E., Rafestin-Oblin M.E. Differential intracellular localization of human mineralocorticoid receptor on binding of agonists and antagonists. Biochem. J. 302:1994;191-197.
37. 3H]aldosterone-type I receptor complex to a DNA-binding species. Life Sci. 43:1988;837-843.
38. MacKintosh C., Klumpp S. Tautomycin from the bacterium Streptomyces verticillatus: another potent and specific inhibitor of protein phosphatases 1 and 2A. FEBS Lett. 277:1990;137-140.
39. Mulkey R.M., Endo S., Shenollkar S., Malenka R.C. Involvement of a calcineurin/inhibitor 1 phosphatase cascade in hippocampal long-term depression. Nature. 369:1994;486-488.
40. Nielsen C.J., Sando J.J., Pratt W.B. Evidence that dephosphorylation inactivated glucocorticoid receptors. Proc. Natl. Acad. Sci. USA. 74:1977;1398-1402.
41. Ortí E., Mendel D.B., Smith L.I., Munck A. Agonist-dependent phosphorylation and nuclear dephosphorylation of glucocorticoid receptors in intact cells. J. Biol. Chem. 263:1989;9728-9731.
42. Ortí E., Bodwell J., Munck A. Phosphorylation of steroid hormone receptors. Endocr. Rev. 13:1992;105-128.
43. Ortí E., Hu L.M., Munck A. Kinetics of glucocorticoid receptor in intact cells. J. Biol. Chem. 268:1993;7779-7784.
44. Patel P.D., Sherman T.G., Goldman D.J., Watson S.J. Molecular cloning of a mineralocorticoid (type I) receptor complementary DNA from rat hippocampus. Mol. Endocrinol. 3:1989;1877-1885.
45. Pratt W.B., Toft D.O. Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr. Rev. 18:1997;306-360.
46. +-ATPase activity in cultured rat skeletal muscle cells. J. Biol. Chem. 272:1997;23653-23658.
47. Reker C.E., LaPointe M.C., Kovacic-Milivojevic B., Chiou W.J.H., Vedeckis W.V. A possible role for dephosphorylation in glucocorticoid receptor transformation. J. Steroid Biochem. 26:1987;653-665.
48. Sasahara Y., Kobayashi T., Onodera H. et al. Okadaic acid suppresses neural differentiation-dependent expression of the neurofilament-L gene in P19 embryonal carcinoma cells by post-transcriptional modification. J. Biol. Chem. 271:1996;25950-25957.
49. Scherrer L.C., Dalman F.C., Massa E., Meshinchi S., Pratt W.B. Structural and functional reconstitution of the glucocorticoid receptor-hsp90 complex. J. Biol. Chem. 265:1990;21397-21400.
50. Silverstein A.M., Galigniana M.D., Chen M.S., Owens-Grillo J.K., Chinkers M., Pratt W.B. Protein Phosphatase 5 is a major component of glucocorticoid receptor-hsp90 complexes with properties of an FK506 binding immunophilin. J. Biol. Chem. 272:1997;16224-16230.
51. Smith D.F., Schowalter D.B., Kost S.L., Toft D.O. Reconstitution of progesterone receptor with heat shock proteins. Mol. Endocrinol. 4:1990;1704-1711.
52. Smith D.F., Stensgard B.A., Welch W.J., Toft D.O. Assembly of progesterone receptor with heat shock proteins and receptor activation are ATP mediated events. J. Biol. Chem. 269:1992;1350-1356.
53. Smith D.F., Whitesell L., Nair S.C., Chen S., Prapapanich V., Rimerman R.A. Progesterone receptor structure and function altered by geldanamycin, an hsp90-binding agent. Mol. Cell. Biol. 15:1995;6804-6812.
54. Takimoto G.S., Hovland A.R., Tasset D.M., Melville M.Y., Tung L., Horwitz K.B. Role of phosphorylation on DNA binding and transcriptional functions of human progesterone receptor. J. Biol. Chem. 271:1996;13308-13316.
55. Trapp T., Holsboer F. Ligand-induced conformational changes in the mineralocorticoid receptor analyzed by protease mapping. BBRC. 215:1995;286-291.
56. Veleiro A.S., Nevado M.V., Monteserín M.C., Burton G. Syntheses of 21-hydroxy-11,19-oxidopregnan-4-ene-3,20-dione and 21-hydroxy-6,19-oxidopregnan-4-ene-3,20-dione. Steroids. 60:1996;268-271.
57. Vicent G.P., Monteserín M.C., Veleiro A.S., Burton G., Lantos C.P., Galigniana M. D. 21-Hydroxy-6,19-oxidoprogesterone: a novel synthetic steroid with specific antiglucocorticoid properties in the rat. Mol. Pharmacol. 52:1997;749-753.
58. Webster J.C., Jewell C.M., Bodwell J.E., Munck A., Sar M., Cidlowski J.A. Mouse glucocorticoid receptor phosphorylation status influences multiple functions of the receptor protein. J. Biol. Chem. 272:1997;9287-9293.
59. Weigel N.L., Carter N.H., Schrader W.T., O' Malley B.W. Chicken progesterone receptor is phosphorylated by a DNA-dependent protein kinase during in vitro transcription assays. Mol. Endocrinol. 6:1992;8-14.
60. Whitesell L., Cook P. Stable and specific binding of hsp90 by geldanamycin disrupts glucocorticoid receptor function in intact cells. Mol. Endocrinol. 10:1996;705-712.
61. Zhang Y., Beck C.A., Poletti A., Edwards D.P., Weigel N.L. Identification of a group of Ser-Pro motif hormone-inducible phosphorylation sites in the human progesterone receptor. Mol. Endocrinol. 9:1995;1029-1040.